Skip to main content

Table 2 Summary of expression-validated genes (EVGs) from predicted transcripts over the entire human genome

From: A comprehensive transcript index of the human genome generated using microarrays and computational approaches

Gene categories Sanger/PTI chromosome 20 Non-Sanger PTI chromosome 20 Sanger/PTI chromosome 22 Non-Sanger PTI chromosome 22 PTI genome-wide
Total Sanger genes represented 1,177 (826)   854 (575)   
RefSeq 676 (552) 8 (2) 375 (290) 12 (5) 10,720 (7992)
Ab initio + expressed sequence + protein 336 (229) 10 (2) 285 (202) 10 (5) 8,801 (4269)
Ab initio + expressed sequence 38 (17) 96 (8) 28 (15) 74 (8) 3,733 (784)
Ab initio + protein 28 (9) 37 (7) 31 (16) 29 (4) 1,983 (233)
Expressed sequence + protein 38 (2) 37 (2) 36 (10) 24 (4) 1,126 (271)
Expressed sequence 22 (3) 1,591 (44) 31 (3) 1,127 (33) 7,170 (1428)
Ab initio 22 (12) 674 (39) 50 (35) 362 (17) 16,822 (555)
Protein 17 (2) 157 (7) 18 (4) 121 (4) 540 (110)
High-confidence categories 1,116 (809) 188 (21) 755 (533) 149 (26) 26,363 (13,549)
All categories 1,177 (826) 2,610 (111) 854 (575) 1,759 (80) 50,895 (15,642)
  1. Columns 1 and 3 provide the total number of Sanger genes for each category for chromosomes 20 and 22, respectively, with the number of EVGs detected given in parentheses. Columns 2 and 4 provide the total number of LPs that did not overlap Sanger genes, with the number of EVGs detected given in parentheses. The last column provides the total number of LPs in the PTI represented on the PTA microarrays, with the number of EVGs detected over the entire genome given in parentheses.